Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Arrowhead Pharmaceuticals, Inc. ARWR

Set alert

Price alert · ARWR

All alert types
59.57 USD -0.33 -0.55%

At close · Nov 2

58.74 -0.83 -1.39%

After hours · Nov 2, 4:00 PM ET

Bid
59.58 × 2
Ask
59.59 × 2
59.41 Day range 61.17
37.06 52-week range 95.49
YTD
-10.27%
1 year
+40.53%
Open
60.55
Prev close
59.90
Mkt cap
8.39B
Vol
1.31M
Avg vol
1.72M
EPS
-2.28
P/E
0.00
Div yield
0.00%
More statistics
Low
59.41
High
61.17
Forward P/E
-11.97
Beta
1.37
Short ratio
4.41
Inst. own
85.26%
Dividend
0.00
Ex-div date
Earnings
Nov 24, 2026
50-d avg
69.79
200-d avg
71.73
1y target
107.71

5D chart

Chart tools
Interval
1m5m15m30m

Signals (125)
NameTimeAgo
SMA: BearishNov 2, 3:55 PM15 hours ago
SMA: BearishNov 2, 3:55 PM15 hours ago
MACD: Sell SignalNov 2, 3:55 PM15 hours ago
SMA: BullishNov 2, 3:35 PM15 hours ago
SMA: BearishNov 2, 3:30 PM15 hours ago
SMA: BullishNov 2, 2:50 PM16 hours ago
SMA: BearishNov 2, 2:45 PM16 hours ago
SMA: BullishNov 2, 2:40 PM16 hours ago
MACD: Buy SignalNov 2, 2:35 PM16 hours ago
MACD: Sell SignalNov 2, 1:20 PM17 hours ago
SMA: BearishNov 2, 1:15 PM17 hours ago
MACD: Buy SignalNov 2, 1:10 PM17 hours ago
SMA: BullishNov 2, 12:55 PM18 hours ago
SMA: BearishNov 2, 12:05 PM18 hours ago
SMA: BullishNov 2, 11:35 AM19 hours ago
SMA: BullishNov 2, 11:00 AM19 hours ago
SMA: BearishNov 2, 10:55 AM20 hours ago
SMA: BearishNov 2, 10:30 AM20 hours ago
MACD: Sell SignalNov 2, 10:30 AM20 hours ago
SMA: BullishNov 2, 10:20 AM20 hours ago

Newest 20 of 125.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 107.71 +80.8% upside
Target (low)
74.00
Target (mean)
107.71
Target (high)
126.00
Ratings (0m) 15 14 buy · 1 hold · 0 sell
  • Strong buy4
  • Buy10
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 14
  • 2 months ago 12

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ARWR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.50-3.00 – -0.34527-0.18-735.1%60.44M-76.4%15
Next quarter-1.37-1.75 – -1.000.22-721.0%45.76M-82.7%7
Current year-3.51-5.14 – -2.45-0.01-35034.2%464.14M-44.0%15
Next year-4.98-6.58 – -2.66-3.51-41.7%328.22M-29.3%15

Upgrades and downgrades

The latest rating changes

ARWR analyst upgrades and downgrades
DateFirmActionFromTo
Oct 15, 2026Chardan CapitalMaintainedBuyBuy
Oct 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 8, 2026CitigroupInitiated—Buy
Sep 1, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 31, 2026Chardan CapitalMaintainedBuyBuy
Aug 31, 2026RBC CapitalReiteratedOutperformOutperform
Aug 6, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 30, 2026B. Riley SecuritiesMaintainedBuyBuy
Jul 27, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 23, 2026Morgan StanleyMaintainedOverweightOverweight
Jul 23, 2026Piper SandlerReiteratedOverweightOverweight
Jul 22, 2026Chardan CapitalMaintainedBuyBuy
Jul 17, 2026JP MorganMaintainedOverweightOverweight
Jul 14, 2026StifelInitiated—Buy
Jul 1, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jun 30, 2026Chardan CapitalMaintainedBuyBuy
Jun 17, 2026Leerink PartnersMaintainedMarket PerformMarket Perform
May 13, 2026BernsteinMaintainedMarket PerformMarket Perform
May 8, 2026RBC CapitalMaintainedOutperformOutperform
May 1, 2026JP MorganInitiated—Overweight
Apr 21, 2026Morgan StanleyUpgradeEqual-WeightOverweight
Mar 25, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 10, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 22, 2026B. Riley SecuritiesMaintainedBuyBuy
Jan 21, 2026HC Wainwright & Co.MaintainedBuyBuy
Jan 13, 2026Piper SandlerReiteratedOverweightOverweight
Jan 7, 2026Goldman SachsMaintainedNeutralNeutral
Jan 7, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jan 7, 2026Chardan CapitalMaintainedBuyBuy
Dec 17, 2025Piper SandlerMaintainedOverweightOverweight